» Authors » W Ostertag

W Ostertag

Explore the profile of W Ostertag including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 158
Citations 1556
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Amagai T, Hitomi S, Sakai Y, Komatsubara-Takagi S, Stocking C, Ostertag W
Mol Cell Neurosci . 2009 Nov; 2(1):6-12. PMID: 19912778
Schwann cell cultures prepared from murine sciatic nerves (MuSN), rat sciatic nerves (RSN) and murine dorsal root ganglia (MuDRG) were transformed by the introduction of oncogenes (v-arc, c-Ha-ras, and v-mos)....
2.
Li Z, Fehse B, Schiedlmeier B, Dullmann J, Frank O, Zander A, et al.
Leukemia . 2002 Aug; 16(9):1655-63. PMID: 12200677
Many applications of hematopoietic gene therapy require selection for clones with active transgene expression. However, it was unclear whether the clonal progeny of a retrovirally transduced hematopoietic stem cell would...
3.
Klump H, Schiedlmeier B, Vogt B, Ryan M, Ostertag W, Baum C
Gene Ther . 2001 Jun; 8(10):811-7. PMID: 11420646
Retroviral vector-mediated expression of the homeoboxgene, HoxB4, in hematopoietic cells has been reported to mediate a benign expansion of gene-modified hematopoietic stem and precursor cells in vivo. In the present...
4.
Prassolov V, Meyer J, Brandenburg G, Hannemann J, Bergemann J, Ostertag W, et al.
Exp Hematol . 2001 May; 29(6):756-65. PMID: 11378271
Objective: A truncated common beta chain (Deltabeta(C)) of the interleukin-3 (IL-3) receptor complex was previously identified as a key factor in inducing autonomous growth of IL-3-independent mutants. Expression of Deltabeta(C)...
5.
Knipper R, Kuehlcke K, Schiedlmeier B, Hildinger M, Lindemann C, Schilz A, et al.
Gene Ther . 2001 Apr; 8(3):239-46. PMID: 11313796
We describe the functional analysis of a novel retroviral vector, SF91m3, which was designed for improved expression of the in vivo selectable marker, multidrug resistance 1 gene (MDR1), in hematopoietic...
6.
Baum C, Richters A, Ostertag W
Curr Opin Mol Ther . 2001 Mar; 1(5):605-12. PMID: 11249667
Gene transfer vectors based on simple retroviruses and more complex lentiviruses are currently the most reliable tools for stable establishment of transgenes in hematopoietic cells. While important hurdles in basic...
7.
Beyer W, Miletic H, Ostertag W, von Laer D
J Virol . 2001 Jan; 75(2):1061-4. PMID: 11134321
Cytoplasmic vector systems are generally used for expression of lymphocytic choriomeningitis virus (LCMV) proteins. However, we achieved high levels of cell surface glycoproteins using a standard nuclear expression plasmid. Expression...
8.
Laker C, Friel J, Franz M, Hara T, Papadopoulos P, Ostertag W, et al.
Exp Cell Res . 2000 Aug; 259(1):1-11. PMID: 10942574
Retroviral insertional mutagenesis has proven to be a powerful in vivo approach for identifying genetic mutations involved in tumorigenesis or developmental abnormalities. Applying this approach to an in vitro system,...
9.
Fehse B, Richters A, Klump H, Li Z, Ostertag W, Zander A, et al.
Mol Ther . 2000 Aug; 1(5 Pt 1):448-56. PMID: 10933966
This study presents a promising selection system for gene-modified cells other than human hematopoietic progenitor and endothelial cells based on transgenic expression of human CD34. Three retrovirally transduced variants of...
10.
von Laer D, Corovic A, Vogt B, Fehse B, Roscher S, Rimek A, et al.
Leukemia . 2000 May; 14(5):947-8. PMID: 10803533
No abstract available.